<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方Info | wechat-feeds</title><link>http://MzU2MTcxOTAwMw.favicon.privacyhide.com/favicon.ico</link><description>传递医药信息，分享资源数据！充电5分钟，吹牛2小时！</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 31 May 2021 12:18:19 +0800</pubDate><image><url>http://MzU2MTcxOTAwMw.favicon.privacyhide.com/favicon.ico</url><title>医药魔方Info | wechat-feeds</title><link>http://MzU2MTcxOTAwMw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>首个国产一线肝细胞癌靶向药物即将获批上市</title><link>https://mp.weixin.qq.com/s/EG9jvFGxUmSsg84GKVVVYg</link><description></description><content:encoded><![CDATA[首个国产一线肝细胞癌靶向药物即将获批上市]]></content:encoded><pubDate>Mon, 31 May 2021 11:27:07 +0800</pubDate></item><item><title>信达生物信迪利单抗第3项适应症即将获批，一线治疗鳞状NSCLC</title><link>https://mp.weixin.qq.com/s/IWgwwoZD8UB_f8WUtJ_Cuw</link><description></description><content:encoded><![CDATA[信达生物信迪利单抗第3项适应症即将获批，一线治疗鳞状NSCLC]]></content:encoded><pubDate>Mon, 31 May 2021 11:27:07 +0800</pubDate></item><item><title>第2家！豪森药业「厄洛替尼片」通过一致性评价</title><link>https://mp.weixin.qq.com/s/irvILv2BqBUM5agyNGRMrQ</link><description></description><content:encoded><![CDATA[第2家！豪森药业「厄洛替尼片」通过一致性评价]]></content:encoded><pubDate>Mon, 31 May 2021 11:27:07 +0800</pubDate></item><item><title>扬子江1类新药「注射用磷酸左奥硝唑酯二钠」获批上市</title><link>https://mp.weixin.qq.com/s/9ffqRUEwBroCZE7XY2NFxg</link><description></description><content:encoded><![CDATA[扬子江1类新药「注射用磷酸左奥硝唑酯二钠」获批上市]]></content:encoded><pubDate>Mon, 31 May 2021 11:27:07 +0800</pubDate></item><item><title>第五批国采品种5月过评情况汇总（附完整清单下载）</title><link>https://mp.weixin.qq.com/s/RbikmjNPSfRFJ8P0uW4XAQ</link><description></description><content:encoded><![CDATA[第五批国采品种5月过评情况汇总（附完整清单下载）]]></content:encoded><pubDate>Sun, 30 May 2021 19:21:57 +0800</pubDate></item><item><title>第四批国采，全国31省市已全部落地执行</title><link>https://mp.weixin.qq.com/s/4KWIGFP0WmVcUGRmFYflfQ</link><description></description><content:encoded><![CDATA[第四批国采，全国31省市已全部落地执行]]></content:encoded><pubDate>Sun, 30 May 2021 19:21:57 +0800</pubDate></item><item><title>重磅！安进AMG 510获FDA加速批准上市</title><link>https://mp.weixin.qq.com/s/65qTCDKQJtUjFCxXkR9HvQ</link><description></description><content:encoded><![CDATA[重磅！安进AMG 510获FDA加速批准上市]]></content:encoded><pubDate>Sat, 29 May 2021 02:53:00 +0800</pubDate></item><item><title>直播预告 | 各家药品专利期限补偿谁更赚？专利法第四次修改对国内上市药品的影响</title><link>https://mp.weixin.qq.com/s/ME5_-uVZ652GJAsv5nocfQ</link><description></description><content:encoded><![CDATA[直播预告 | 各家药品专利期限补偿谁更赚？专利法第四次修改对国内上市药品的影响]]></content:encoded><pubDate>Sat, 29 May 2021 02:53:00 +0800</pubDate></item><item><title>肿瘤浸润淋巴细胞疗法BLA再遭延迟，CEO离职，公司股价暴跌</title><link>https://mp.weixin.qq.com/s/6mhjx2KQ5Cz4zyZEA59VZQ</link><description></description><content:encoded><![CDATA[肿瘤浸润淋巴细胞疗法BLA再遭延迟，CEO离职，公司股价暴跌]]></content:encoded><pubDate>Fri, 28 May 2021 18:20:56 +0800</pubDate></item><item><title>百时美施贵宝 S1PR1/5 调节剂新适应症获FDA批准，治疗溃疡性结肠炎</title><link>https://mp.weixin.qq.com/s/SPjaxkLsDNMBKK4eSqF8SA</link><description></description><content:encoded><![CDATA[百时美施贵宝 S1PR1/5 调节剂新适应症获FDA批准，治疗溃疡性结肠炎]]></content:encoded><pubDate>Fri, 28 May 2021 18:20:56 +0800</pubDate></item><item><title>医药魔方前沿趋势研究主题分享会 | 南京站</title><link>https://mp.weixin.qq.com/s/njLg_5oVak3qAc7HFKprJQ</link><description></description><content:encoded><![CDATA[医药魔方前沿趋势研究主题分享会 | 南京站]]></content:encoded><pubDate>Fri, 28 May 2021 18:20:56 +0800</pubDate></item><item><title>基石药业PD-L1治疗III期NSCLC注册性临床试验成功，拟递交新药上市申请</title><link>https://mp.weixin.qq.com/s/J28c8cxEEj30z3htYdGlIA</link><description></description><content:encoded><![CDATA[基石药业PD-L1治疗III期NSCLC注册性临床试验成功，拟递交新药上市申请]]></content:encoded><pubDate>Fri, 28 May 2021 18:20:56 +0800</pubDate></item><item><title>贝达药业「埃克替尼片」新适应症即将获批，NSCLC术后辅助治疗</title><link>https://mp.weixin.qq.com/s/W1gGcRtLAc4vGfQQQiDAEA</link><description></description><content:encoded><![CDATA[贝达药业「埃克替尼片」新适应症即将获批，NSCLC术后辅助治疗]]></content:encoded><pubDate>Fri, 28 May 2021 18:20:56 +0800</pubDate></item><item><title>扬子江1类新药「注射用磷酸左奥硝唑酯二钠」即将获批</title><link>https://mp.weixin.qq.com/s/54gvl1TN4FyEXZcc3PFAmg</link><description></description><content:encoded><![CDATA[扬子江1类新药「注射用磷酸左奥硝唑酯二钠」即将获批]]></content:encoded><pubDate>Fri, 28 May 2021 18:20:56 +0800</pubDate></item><item><title>传奇生物BCMA CAR-T上市申请获FDA优先审评</title><link>https://mp.weixin.qq.com/s/SFoFU9P4dJewcj6h1cvNyg</link><description></description><content:encoded><![CDATA[传奇生物BCMA CAR-T上市申请获FDA优先审评]]></content:encoded><pubDate>Thu, 27 May 2021 10:57:26 +0800</pubDate></item><item><title>阿斯利康中国与博安生物达成重磅战略合作，助力本土抗肿瘤生物药扩面县域市场</title><link>https://mp.weixin.qq.com/s/4H7APUn6ifpQ7am849wjlQ</link><description></description><content:encoded><![CDATA[阿斯利康中国与博安生物达成重磅战略合作，助力本土抗肿瘤生物药扩面县域市场]]></content:encoded><pubDate>Thu, 27 May 2021 10:57:26 +0800</pubDate></item><item><title>璎黎药业/恒瑞选择性PI3Kδ抑制剂上市申请拟优先审评</title><link>https://mp.weixin.qq.com/s/L8gTY7KMJIt5HgFB1PCPrw</link><description></description><content:encoded><![CDATA[璎黎药业/恒瑞选择性PI3Kδ抑制剂上市申请拟优先审评]]></content:encoded><pubDate>Thu, 27 May 2021 10:57:26 +0800</pubDate></item><item><title>苏建华博士出任岸迈生物CSO</title><link>https://mp.weixin.qq.com/s/0Lq8MJeMLn-QDp1ou4lfHw</link><description></description><content:encoded><![CDATA[苏建华博士出任岸迈生物CSO]]></content:encoded><pubDate>Thu, 27 May 2021 10:57:26 +0800</pubDate></item><item><title>研发人才向本土Biotech汇聚，下一个趋势是什么？</title><link>https://mp.weixin.qq.com/s/8ZltyzS4DUdk0ayV2HDI9A</link><description></description><content:encoded><![CDATA[研发人才向本土Biotech汇聚，下一个趋势是什么？]]></content:encoded><pubDate>Wed, 26 May 2021 17:53:45 +0800</pubDate></item><item><title>进军生物药领域！南京诺唯赞IPO过会，将上科创板</title><link>https://mp.weixin.qq.com/s/fPpwSLCVGKU2vpbC52741g</link><description></description><content:encoded><![CDATA[进军生物药领域！南京诺唯赞IPO过会，将上科创板]]></content:encoded><pubDate>Wed, 26 May 2021 17:53:45 +0800</pubDate></item></channel></rss>